Send feedback

MDM2 p.Gln272Arg

c.815A>G · rs1883277329 · VCV2859179

Uncertain significance Single submitter
Classification
Uncertain significance
ClinVar
Review
Single submitter ★☆☆☆
ClinVar · 1 submitter
AlphaMissense
likely benign
0.0968 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.00223%, eas)
Missense predictors
0/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
1
Accelerated tumor formation, susceptibility to

Computational evidence

Protein change
AlphaMissense0.0968likely benign
REVEL0.048moderately benign-leaning
SaProtLLR -6.26tolerated
⇒ AlphaMissense, REVEL and SaProt all call this tolerated.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 5.9GERP 1.9, phastCons 1
Regional constrainto/e 0.71unconstrained · MANE · 19 kb · p 8.3e-06 · regional, not allelic
Overall
CADD21.1PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

⚠ Isoform check: AlphaMissense numbered on a different transcript (AM Q266R vs ClinVar Q272R) — verify the residue.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00223% East Asian · 1/44,780 alleles
Filtering AF 2.8e-05% ClinGen BA1/BS1 input FAF95, joint · FAF99 1.1e-05%
Overall 0.000311% 5/1,609,594 alleles · very rare
Ancestry group Frequency 1 in
Remaining individualsnot grpmax-eligible 0.00321% 31,140
East Asiangrpmax 0.00223% 44,780
European (non-Finnish) 0.00017% 588,814

Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
MDM2
Protein
p.Gln272Arg
Coding
c.815A>G
MANE Select
NM_002392
dbSNP
rs1883277329
Type
single nucleotide variant
Location
chr12:68835959 (GRCh38)
Gene constraint
LOEUF 0.325 · pLI 1.00 (gnomAD)
Structure
AlphaFold pLDDT 63.24 · 148 PDB
Residue 272
the 'arf-binding' region; the 'region ii' region; the 'disordered' region; the 'interaction with mtbp' region; the 'mediates interaction with rad54b' region
Full MDM2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/mdm2-p-gln272arg (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown